Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Long-term potentiation | R-HSA-9620244 | map04720 | cinchocaine | 3025 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | amiloride | 16231 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | amiloride | 16231 | drug-path |
Primary immunodeficiency | R-HSA-5601905 | map05340 | amiloride | 16231 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | amiloride | 16231 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | amiloride | 16231 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | amiloride | 16231 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | amiloride | 16231 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | amiloride | 16231 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | amiloride | 16231 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | amiloride | 16231 | drug-path |
Asthma | R-HSA-444620 | map05310 | amiloride | 16231 | drug-path |
Basal transcription factors | R-HSA-3232118 | map03022 | amiloride | 16231 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | amiloride | 16231 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | amiloride | 16231 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | amiloride | 16231 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | amiloride | 16231 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | amiloride | 16231 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | amiloride | 16231 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | levodopa | 6047 | drug-path |